SCHEMBL6026702

SCHEMBL6026702

CC(=O)Nc1cccc(OCc2ccc(C(=O)O)cc2)c1C=O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.59
RXRA P19793 8/20 0.52
RXRB P28702 7/20 0.52
RXRG P48443 6/20 0.52
HPGD P15428 3/20 0.49
FOLH1 Q04609 1/20 0.48
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
PTGER1 P34995 1/20 0.44
PTGER4 P35408 1/20 0.44
PTGER3 P43115 1/20 0.44
PTGER2 P43116 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026989 0.86 BRD4 (0.51) BRD4HPGDALDH1A1MEN1KMT2A
SCHEMBL10923316 0.82 BRD4 (0.46) BRD4HPGDALDH1A1MEN1KMT2A
SCHEMBL23363642 0.81 RXRA (0.56) RXRARXRBRXRGHPGDFOLH1
SCHEMBL30495975 0.81 RXRA (0.56) RXRARXRBRXRGHPGDFOLH1
SCHEMBL21798467 0.81 RXRA (0.70) RXRARXRBRXRGHPGDFOLH1
SCHEMBL23383976 0.81 RXRA (0.70) RXRARXRBRXRGHPGDFOLH1
Tucaresol SCHEMBL600942 0.80 RXRA (0.56) RXRARXRBRXRGHPGDFOLH1
Tucaresol SCHEMBL29400654 0.80 RXRA (0.56) RXRARXRBRXRGHPGDFOLH1
SCHEMBL31562821 0.80 PTGDR2 (0.50) BRD4HPGDALDH1A1MEN1KMT2A
SCHEMBL17826400 0.77 FOLH1 (0.54) RXRARXRBRXRGHPGDFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US claimed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP claimed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO claimed
US-7074770-B1 Method of DNA vaccination SMITHKLINE BEECHAM CORPORATION (US) 2006-07-11 US disclosed
EP-1107785-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2001-06-20 EP disclosed
WO-2000012121-A1 METHOD OF DNA VACCINATION GLAXO GROUP LIMITED (GB) 2000-03-09 WO disclosed
EP-0614357-A1 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-09-14 EP disclosed
WO-1994007479-A2 IMMUNOPOTENTIATORY AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-04-14 WO disclosed
EP-0054924-B1 PHARMACEUTICAL COMPOUNDS, THEIR PREPARATION AND USE THE WELLCOME FOUNDATION LIMITED (GB) 1986-08-06 EP disclosed
US-4535183-A PALLIATION OF SICKLE CELL ANEMIA, RESPIRATORY DISORDERS, HYPOXIA, RADIOSENSITIZATION OF TUMORS BURROUGHS WELLCOME CO. (US) 1985-08-13 US disclosed
EP-0054924-A2 Pharmaceutical compounds, their preparation and use THE WELLCOME FOUNDATION LIMITED (GB) 1982-06-30 EP disclosed